Consolidated Planning Corp Merck & Co., Inc. Transaction History

Consolidated Planning Corp

$710 Million
Q2 2025

A detailed history of Consolidated Planning Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Consolidated Planning Corp holds 3,364 shares of MRK stock, worth $289,270. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,364

Previous 4,750 29.18%

Holding current value

$289,270

Previous $426,000 37.56%

% of portfolio

0.04%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	SELL	$73.47 - $87.12 $101,829 - $120,748	-1,386 Reduced 29.18%	3,364 $266,000
Q1 2025 Apr 22, 2025	SELL	$83.01 - $101.02 $332 - $404	-4 Reduced 0.08%	4,750 $426,000
Q4 2024 Jan 29, 2025	SELL	$96.31 - $114.76 $4.2 Million - $5 Million	-43,611 Reduced 90.17%	4,754 $472,000
Q3 2024 Oct 31, 2024	SELL	$111.15 - $128.97 $136,714 - $158,633	-1,230 Reduced 2.48%	48,365 $5.49 Million
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $613,429 - $658,816	4,955 Added 11.1%	49,595 $6.14 Million
Q1 2024 May 02, 2024	BUY	$113.24 - $131.95 $203,152 - $236,718	1,794 Added 4.19%	44,640 $5.89 Million
Q4 2023 Feb 02, 2024	BUY	$100.18 - $109.02 $129,833 - $141,289	1,296 Added 3.12%	42,846 $4.67 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $213,930 - $237,577	2,078 Added 5.26%	41,550 $4.28 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $259,252 - $282,573	2,387 Added 6.44%	39,472 $4.55 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $962,900 - $1.07 Million	9,354 Added 33.73%	37,085 $3.95 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $2.12 Million - $2.71 Million	24,193 Added 683.8%	27,731 $3.08 Million
Q3 2022 Nov 04, 2022	BUY	$84.53 - $94.96 $23,668 - $26,588	280 Added 8.59%	3,538 $305,000
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $45,919 - $52,052	550 Added 20.31%	3,258 $297,000
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $147 - $164	-2 Reduced 0.07%	2,708 $222,000
Q3 2021 Nov 17, 2021	SELL	$71.68 - $78.83 $2,508 - $2,759	-35 Reduced 1.28%	2,710 $204,000
Q2 2021 Jul 26, 2021	SELL	$70.31 - $77.77 $11,601 - $12,832	-165 Reduced 5.67%	2,745 $213,000
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $7,182 - $8,173	102 Added 3.63%	2,910 $225,000
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $6,336 - $8,782	100 Added 3.69%	2,808 $216,000
Q4 2019 Apr 29, 2020	BUY	$77.58 - $87.54 $210,086 - $237,058	2,708 New	2,708 $246,000

Others Institutions Holding MRK

# of Institutions

3,842

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $218B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.

Account

Consolidated Planning Corp Merck & Co., Inc. Transaction History